Okumura N, Soh J, Suzuki H, Nakata M, et al. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301. BMC Cancer 2021;21:506.
PMID: 33957881